Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1Genitourinary 1Dermatologic 1CNS 1Breast 1

Conditions

Multiple Myeloma 17Neoplasms, Plasma Cell 13Leukemia, Lymphocytic, Chronic, B-Cell 5Lymphoma, Non-Hodgkin 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Follicular 4Lymphoma, B-Cell, Marginal Zone 4Lymphoma 4Leukemia 4Immunoglobulin Light-chain Amyloidosis 4Burkitt Lymphoma 4Waldenstrom Macroglobulinemia 3Primary Myelofibrosis 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Myeloproliferative Disorders 3Myelodysplastic Syndromes 3Lymphoma, Mantle-Cell 3Leukemia, Myeloid, Chronic-Phase 3Leukemia, Myeloid, Acute 3Leukemia, Myeloid, Accelerated Phase 3Leukemia, Hairy Cell 3Hodgkin Disease 3Blast Crisis 3Thrombocythemia, Essential 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Precancerous Conditions 2Polycythemia Vera 2Monoclonal Gammopathy of Undetermined Significance 2Lymphoma, Large-Cell, Anaplastic 2

Interventions

fludarabine phosphate 30Peripheral Blood Stem Cell Transplantation 30Mycophenolic Acid 23Whole-Body Irradiation 19Tacrolimus 19Cyclosporine 19Cyclophosphamide 19Antilymphocyte Serum 14Busulfan 13Methotrexate 12Methylprednisolone 9Filgrastim 9Radiotherapy 8Flow Cytometry 8Melphalan 7Cord Blood Stem Cell Transplantation 7Polymerase Chain Reaction 6Transplantation 5Therapeutics 5Psychiatric Rehabilitation 5Etoposide 5Sirolimus 4Ondansetron 4sargramostim 3merphos 3Everolimus 3Epoetin Alfa 3Early Intervention, Educational 3Dexamethasone 3Darbepoetin alfa 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sezary Syndrome × Interferon-alpha × Plasma cell × Clear all
NCT00003408 2013-03-26

Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer

National Cancer Institute (NCI)

Phase 2 Completed
40 enrolled
BreastCNSDermatologicGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Teratoma, Testicular, Testicular Germ Cell Tumor, Carcinoma, Ovarian Epithelial, Blast Crisis, Breast Neoplasms, Burkitt Lymphoma, Hodgkin Disease, Kidney Neoplasms, Leukemia, Leukemia, Hairy Cell, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Mycosis Fungoides, Myelodysplastic Syndromes, Myeloproliferative Disorders, Wilms Tumor, Neuroblastoma, Ovarian Neoplasms, Recurrence, Sarcoma, Sezary Syndrome, Teratoma, Testicular Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Carcinoma, Embryonal, Seminoma, Endodermal Sinus Tumor, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Gestational Trophoblastic Disease, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Dendritic Cell Sarcoma, Interdigitating, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡